TriAltus Bioscience
Boulder, United States· Est. 2021
Genomic Enzyme Portfolio. Our purified CRISPR and other genomic enzymes outperform industry standards in both quality and affordability, making us the trusted by leading innovators
Private Company
Total funding raised: $3.2M
About
Genomic Enzyme Portfolio. Our purified CRISPR and other genomic enzymes outperform industry standards in both quality and affordability, making us the trusted by leading innovators
BiologicsAntibodies
Funding History
1Total raised:$3.2M
Seed$3.2MMay 15, 2023